spacer
home > ebr > winter 2001 > the credibility gap - intellectual property rights, access to drugs and bioterrorism
PUBLICATIONS
European Biopharmaceutical Review

The Credibility Gap - Intellectual Property Rights, Access to Drugs and Bioterrorism

The issue of intellectual property rights (IPR) and access to drugs has once again been thrown under the spotlight as a result of the recent bioterrorist attacks on the US - but this time with an ironic twist: it has been the very countries that blocked the efforts of developing nations to override IPR to obtain access to key drugs that have recently threatened to do just that. So, in an attempt to procure mass quantities of antibiotics with which to treat anthrax poisoning - and amid threats to contract generic firms to ensure adequate supplies of Bayer AG's drug Cipro/Ciprobay (ciprofloxacin) - did the US and Canada undermine long-held positions and political credibility on pharmaceutical IPR in the run-up to the World Trade Organization (WTO) negotiations in Doha (Qatar, 9th-14th November)?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Henry Dummett, Africa and North America Analyst for World Markets Healthcare

Henry Dummett is the Africa and North America analyst for World Markets Healthcare, the new analytical information service for the global healthcare market from the World Markets Research Centre (WMRC). Henry is a graduate in Modern History from St. Anne's College, Oxford and has an MSc in African Politics from the School of Oriental and African Studies (SOAS).

spacer
Henry Dummett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Quinten Health Closes its Financing Round to Advance Disease Modelling Platforms and Virtual Twins in Real-World

Paris, September 21st, 2022 Life Science Newswire QUINTEN HEALTH, a pioneer in real-world data science, Artificial Intelligence (AI) and Machine Learning (ML) for precision care, today announces that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world, as part of the Quinten Group's 14 million growth equity investment from TECHLIFE CAPITAL and MACSF, essentially dedicated to the healthcare activities of the Quinten group.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement